Common variable immunodeficiency: a new look at an old disease.

Area of Science:

• Immunology
• Genetics
• Clinical Medicine

Background:

• Primary immunodeficiencies (PIDs) encompass over 150 rare genetic diseases impacting the immune system.
• The prevalence of PIDs varies globally, influenced by diagnostic capabilities.
• Common variable immunodeficiency (CVID) is the most frequent PID in clinical settings, significantly affecting patient health and healthcare costs.

Purpose of the Study:

• To highlight the significance of timely diagnosis and management of CVID.
• To discuss the impact of recent advancements in diagnostic methods on CVID classification.
• To underscore the importance of understanding the molecular basis of immune dysfunction in CVID.

Main Methods:

• Review of current diagnostic laboratory methods for PIDs, including B-cell subset analysis and genetic testing.
• Analysis of recent insights into the molecular mechanisms underlying immune dysfunction in CVID.
• Examination of updated clinical classifications for heterogeneous CVID cases.

Main Results:

• Identification of over 150 distinct primary immunodeficiency diseases with more than 120 associated genetic defects.
• Demonstration that advancements in B-cell subset analysis and genetic testing enhance PID diagnosis.
• Improved clinical classification of CVID is achievable through a deeper understanding of its molecular basis.

Conclusions:

• Accurate diagnosis and management of CVID are crucial for reducing patient morbidity and mortality.
• Technological and molecular advancements are transforming the clinical classification and understanding of CVID.
• Continued research into the genetic and molecular underpinnings of PIDs is essential for improving patient outcomes.